home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

5th European Cardiovascular Safety Conference 2011

 
  May 14, 2011  
     
 
Hilton Barcelona, Barcelona, Spain
Nov 3 2011 9:00AM - Nov 4 2011 5:00PM


Advances in cardiovascular (CV) safety and better understanding of the potential for cardiotoxicity of new drugs in development have recently gained a regulatory and public focus. Concerns involving the CV safety of new anti-diabetes agents have prompted the US FDA to issue a specific guideline calling for sponsors to present a retrospective meta-analysis, or perform a prospective, dedicated, large-scale CV outcome trial prior to, or post-approval. Likewise, the EMA recently released an updated diabetes guideline restating its requirements for demonstrating CV safety of new anti-diabetes drugs.

Similar CV safety issues have also been widely reported for marketed anti-obesity drugs, prompting a high profile worldwide withdrawal of one drug and a FDA non-approval of three other anti-obesity drugs. The later developments highlight the need for better directions for the development of anti-obesity drugs.

Oncology agents have also been implicated with a number of CV safety issues, ranging from QT prolongation and arrhythmia to myocardial tissue toxicity leading to heart failure and possibly premature death, therefore triggering specific regulatory actions. While no formal guidelines have been issued for CV safety of oncology drugs in development, a de-facto compliance with current CV safety standards are expected.

The above topics will be discussed in detail by clinical, regulatory and industry experts at the 5th European DIA Cardiovascular Safety Conference.


Event Code:
11112
 
 
Organized by: DIA Europe
Invited Speakers: See website for speaker information
 
Deadline for Abstracts: Call contact
 
Registration:

DIA Europe

PHONE: +41 61 225 51 51

FAX: +41 61 225 51 52

E-MAIL: DIAEUROPE@DIAEUROPE.ORG

 

 

E-mail: diaeurope@diaeurope.org
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.